Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

COPD: Management Using Bronchodilators and Corticosteroids01:26

COPD: Management Using Bronchodilators and Corticosteroids

Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
Chronic Obstructive Pulmonary Disease-V: Nursing Management01:30

Chronic Obstructive Pulmonary Disease-V: Nursing Management

Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet cell...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Trajectories of early growth and subsequent lung function in cystic fibrosis: An observational study using UK and Canadian registry data.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2022
Same author

Mediation of the total effect of cystic fibrosis-related diabetes on mortality: A UK Cystic Fibrosis Registry cohort study.

Diabetic medicine : a journal of the British Diabetic Association·2022
Same author

Clinimetric analysis of outcome measures for airway clearance in people with cystic fibrosis: a systematic review.

Therapeutic advances in respiratory disease·2022
Same author

Using Negative Control Outcomes and Difference-in-Differences Analysis to Estimate Treatment Effects in an Entirely Treated Cohort: The Effect of Ivacaftor in Cystic Fibrosis.

American journal of epidemiology·2021
Same author

Heterogeneity of treatment response in bronchiectasis clinical trials.

The European respiratory journal·2021
Same author

Incidence and risk factors of cancer in individuals with cystic fibrosis in the UK; a case-control study.

Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society·2021
Same journal

Early Intervention With Biologics for Asthma Remission: Promising or Premature?

Respirology (Carlton, Vic.)·2026
Same journal

Clinical and Inflammatory Phenotypes During Exacerbations Predict In-Hospital Adverse Outcomes in Asthma-COPD Overlap.

Respirology (Carlton, Vic.)·2026
Same journal

Diagnostic Yield of EBUS Mediastinal Cryobiopsy Versus TBNA in Suspected Lymphoproliferative Disorders: A Prospective Multicentre Study.

Respirology (Carlton, Vic.)·2026
Same journal

Association of Airway Mucus Plugs and Physical Activity, Exercise Tolerance, Sarcopenia, and Frailty in Patients With COPD and Pre-COPD.

Respirology (Carlton, Vic.)·2026
Same journal

An Age-Friendly Approach to Caring for Chronic Lung Disease in the Ambulatory Setting.

Respirology (Carlton, Vic.)·2026
Same journal

Supplemental Oxygen Therapy in Advanced Lung Disease-New Evidence Raises New Questions.

Respirology (Carlton, Vic.)·2026
See all related articles

Related Experiment Video

Updated: Jun 21, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Clinical challenges in managing bronchiectasis.

Kenneth W Tsang1, Diana Bilton

  • 1The University of Hong Kong, 1202 Central Building, 1-3 Pedder Street Central, Hong Kong, China. kwttsang@hku.hk

Respirology (Carlton, Vic.)
|August 8, 2009
PubMed
Summary
This summary is machine-generated.

Bronchiectasis, a common lung disease causing chronic sputum and exacerbations, has complex causes and unsatisfactory treatments. Further research is crucial for better understanding and management of this condition.

More Related Videos

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Related Experiment Videos

Last Updated: Jun 21, 2026

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

Area of Science:

  • Pulmonology
  • Infectious Diseases
  • Inflammation Research

Background:

  • Bronchiectasis is prevalent in the Asia-Pacific, characterized by chronic sputum production and recurrent exacerbations.
  • Its etiology is diverse, often idiopathic, with pathogenesis involving infective, inflammatory, and enzymatic factors leading to progressive airway damage.
  • Current treatment options for bronchiectasis are limited and often unsatisfactory, highlighting a need for improved therapeutic strategies.

Purpose of the Study:

  • To review the current understanding of bronchiectasis, focusing on its etiology, pathogenesis, and treatment.
  • To evaluate the efficacy of existing and emerging therapies for bronchiectasis management.
  • To emphasize the need for increased research attention to this neglected respiratory illness.

Main Methods:

  • Literature review of existing studies on bronchiectasis.
  • Analysis of data on the efficacy of inhaled corticosteroids and low-dose macrolides.
  • Discussion of current antibiotic therapy approaches for bronchiectasis, including acute exacerbations and maintenance.

Main Results:

  • Inhaled corticosteroid therapy shows clinical and anti-inflammatory benefits in bronchiectasis.
  • Low-dose macrolides demonstrate some efficacy, but long-term data are needed.
  • Antibiotic therapy for bronchiectasis is complex, involving empirical, maintenance, and various administration routes.

Conclusions:

  • Bronchiectasis pathogenesis involves a complex interplay of infection, inflammation, and enzymatic activity.
  • While some treatments like inhaled corticosteroids and macrolides show promise, further research is essential.
  • Increased research focus on bronchiectasis etiology, pathogenesis, and treatment is critical for improving patient outcomes.